Verily and Crohn’s & Colitis Foundation expand strategic partnership to establish novel registry of patients with inflammatory bowel disease (IBD)

The partnership’s first-of-its-kind participant-centered model will be critical in advancing clinical IBD research

SOUTH SAN FRANCISCO, CA, and NEW YORK, NY, October 25, 2022 — Verily, an Alphabet company focused on precision health, and the Crohn’s & Colitis Foundation, a non-profit organization dedicated to finding cures for Crohn’s disease and ulcerative colitis and to improving the quality of life of children and adults affected by these diseases, announced today an expanded strategic partnership. The collaboration will focus on building a longitudinal registry to accelerate research in Crohn’s disease and in ulcerative colitis, collectively known as inflammatory bowel disease (IBD).

 

Read the full press release here

Crohn's & Colitis Foundation

The Crohn's & Colitis Foundation is a non-profit, volunteer-fueled organization dedicated to finding the cures for Crohn's disease and ulcerative colitis, and to improving the quality of life of children and adults affected by these diseases. It was founded in 1967 by Irwin M. and Suzanne Rosenthal, William D. and Shelby Modell, and Henry D. Janowitz, M.D.